Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Statin Therapy in Acute Ischemic Stroke with Cerebral Microbleeds
NCT05589454Phase 4Not yet recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Jan 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atorvastatin in ischemic stroke (2 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoints: The incidence of hemorrhagic strokes at 36 months and Changes in degree of cerebral microbleeds at 36 months. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05589454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05589454.